Replies to post #129844 on Biotech Values

[HattieTheWitch]

But the back-off portion of the deals are more favorable to NVS than MNTA.

Exactly.

MNTA's patents protect MNTA's interests, but now (because of the AG) NVS benefits more than ever? That doesn't seem right to me at all.